• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

History

30th Anniversary of the International Alliance

Enjoy a video collage that includes photos from the beginning of the Alliance in 1992.

Early Recollections of the Formation of the Organisation

by Mavis Gallienne, Wendy Abrams, Rodney Harris and Peter Cardy, December 2012

The instigation of an international network to support organisations providing a range of services and promoting research into ALS/MND came about in 1987-88, when Peter Cardy commenced as the Chief Executive Officer of the MND Association of England, Wales and Northern Ireland.

The MNDA initiated an annual Research Meeting, which would later become the International Symposium on ALS/MND (the first was called ‘Who Is Out There Researching Into MND?’).

As a result of those early meetings, delegates from ALS/MND associations around the world came to England, and discussions began about forming an international organisation whose aim would be to support associations providing care and services to people living with ALS/MND and also to promote and stimulate research.  From these discussions, the Alliance was eventually born.

Official Notes – Alliance Founding Meeting, Solihull, Birmingham, 4-6 November 1992

Chairpersons of the Alliance since its inception in 1992 have been:

Eithne Frost of the Irish MNDA; Mavis Gallienne of MND Australia; Wendy Abrams of the Les Turner ALS Foundation, USA; Diane Heron of MNDA South Africa; Rod Harris of MND Victoria, Australia; Gudjon Sigurdsson of the MND Iceland; Jeffrey Deitch of the ALS Hope Foundation, USA; Carol Birks of MND Australia; Steve Bell of the Motor Neurone Disease Association of England, Wales and N Ireland; and, since December 2018, Calaneet Balas of ALS Association, USA.

 

Primary Sidebar

About

  • Who We Are
  • Board of Trustees
  • Advisory Councils/Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Archives
    • Newsletters
    • Meetings
  • Awards

  • John Sweeney, USA

    John Sweeney, USA

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Anita Forte, USA

    Anita Forte, USA

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Glen Victor Peters, Australia

    Glen Victor Peters, Australia

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Steve

    Steve

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Bob Simonds, USA

    Bob Simonds, USA

  • Jason Goodman, USA

    Jason Goodman, USA

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Paul Launer, USA

    Paul Launer, USA

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Mike Small, UK

    Mike Small, UK

  • Jay Epstein, USA

    Jay Epstein, USA

  • Mike Rannie, Canada

    Mike Rannie, Canada

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Sally Pauls, USA

    Sally Pauls, USA

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Jean

    Jean
    jean

  • Philip Brindle, England

    Philip Brindle, England

  • Rob Tison, USA

    Rob Tison, USA

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Bayley, Australia

    Bayley, Australia

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Christian Bär, Germany

    Christian Bär, Germany

  • Elkin Ramiro Gaviria Muñoz, Colombia

    Elkin Ramiro Gaviria Muñoz, Colombia

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

Learn more about the March of Faces

Footer

Subscribe to our Bi-monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login